Tumour ablation and hepatic decompensation rates in multi-agent chemoembolization of hepatocellular carcinoma

QJM: An International Journal of Medicine

Volumn 91, Issue 12, 1998, Pages 821-828

  Shah, S R ^a,c   Riordan, S M ^a,c   Karani, J ^b,c   Williams, R ^a,c  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c CROMWELL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; IODINATED POPPYSEED OIL;

ADULT; AGED; ARTERY CATHETER; ARTICLE; ARTIFICIAL EMBOLISM; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DETERIORATION; HOSPITALIZATION; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LIVER ARTERIOGRAPHY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER ISCHEMIA; PRIORITY JOURNAL; RECURRENT CANCER; VASCULARIZATION;

EID: 0032444797     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/91.12.821     Document Type: Article

References (35)

1. Okuda K. Hepatocellular carcinoma: recent progress. Hepatology 1992; 15:948-63.
2. Tagaki H, Uehara M, Sakurai S, Takagi H, Uehara M, Sakurai S, Yumada S, Takayama H, Saitoh S, Ojima T, Yamada T, Abe T, Kobayashi S. Evaluation of non-surgical treatments of hepatocellular carcinoma - investigation of the cases with long and short survivals after treatment. Nippon Gan Chiryo Gakkai Shi 1990; 25:757-69.
3. Johnson PJ, Williams R. Hepatocellular carcinoma. Postgrad Med J 1979; 23:100-9.
4. Ryder SD, Rizzi PM, Metivier E, Karani J, Williams R. Chemoembolisation with lipiodol and doxorubicin: applicability in British patients with hepatocellular carcinoma. Gut 1996; 38:125-8.
5. Okuda K, Obata H, Nakajima Y, Ohtsuki T, Okazaki N, Ohnishi K. Prognosis of primary hepatocellular carcinoma. Hepatology 1984; 4:S3-6.
6. Monna T, Kanno T, Marumo T, Harihara S, Kuroki T, Yamamoto S, Kobayashi N, Sato M, Nakamura K, Nakatsuka H, Onoyama Y, Yamada R. A comparison of transcatheter arterial embolization with one shot therapy for the patients with hepatic cell carcinoma. Gastroentcrol Jpn 1982; 17:542-8.
7. Ikeda K, Kumada H, Saitoh S, Arase Y, Chayama K. Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. Cancer 1991; 68:2150-4.
8. Monden M, Sakon M, Gotoh M, Kanai T, Umeshita K, Wang K, Sakurai M, Kuroda C, Okamura J, Mori T. Selection of therapeutic modalities for hepatocellular carcinoma in patients with multiple hepatic lesions. Cancer Chemother Pharmacol 1992; 31 (Suppl 1):S38-44.
9. Bismuth H, Morino M, Sherlock D, Castaing D, Miglietta C, Cauquil P, Roche A. Primary treatment of hepatocellular carcinoma by arterial chemoembolisation. Am J Surg 1992; 163:387-94.
10. Hsieh M, Chang W, Wang L, Chen S, Chuang W, Lu S, Wu D. Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization and analysis of prognostic factors. Cancer Chemother Pharmacol 1992; 31 (Suppl 1): S82-5.
11. Pirschel J, Lanchart W. Chemoembolization primarer Leberkarzinome mit Epirubicin-Lipiodol. Fortschr Geb Rontgenstr Nuklearmed 1991; 155:409-15.
12. Mondazzi L, Bottelli R, Brambilia G, Rampoldi A, Rezakovic I, Zavaglia C, Alberti A, Ideo G. Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors. Hepatology 1994; 19:1115-23.
13. Civalleri D, Pellicci R, Decaro G, Giangaspero A, Ettore G, Decian F, Mondini G, Simoni G. Palliative chemoembolization of hepatocellular carcinoma with mitoxantrone, lipiodol and gelfoam. Anticancer Res 1996; 16:937-41.
14. Chang JM, Tzeng WS, Pan HB, Yang CF, Lai KH. Transcatheter arterial embolization with or without cisplatin treatment of hepatocellular carcinoma. Cancer 1994; 74:2449-553.
15. Yamada R, Nakatsuka H, Nakamura K, Sato M, Itami M, Kobayashi N, Minakuchi K, Onoyama Y, Kanno T, Monna T, Yamamoto S. Hepatic artery embolisation in 32 patients with unresectable hepatoma. Osaka City Med J 1980; 26:81-96.
16. Sakurai M, Okamura J, Kuroda C. Transcatheter chemoembolisation effective for treating hepatocellular carcinoma: a histopathologic study. Cancer 1984; 54:387-92.
17. Pelletier G, Roche A, Ink O, Anciaux M, Derhy S, Rougier P, Lenoir E, Attali P, Etienne JP. A randomized trial of hepatic arterial chemoembolisation in patients with unresectable hepatocellular carcinoma. J Hepatol 1990; 11:181-4.
18. Groupe d'Etude et de Traitment du Carcinome Hepatocellulaire. Comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 1995; 332:1256-61.
19. Pelletier G, Ducreux M, Broseta V, Hagege H, Dao T, Van Steenbergen V, et al. Groupe CHC2. Essai randomise de la chimioembolisation lipiodolee (CEL) dans le traitment du carcinome hepatocellulaire (CHC) non resecable. Gastroenterol Clin Biol 1996; 20:A182.
20. Vetter D, Wenger J, Bergier J, Doffoel M, Bockel R. Transcatheter oily chemoembolisation in the management of advanced hepatocellular carcinoma in cirrhosis: results of a Western comparative study in 60 patients. Hepatology 1991; 13:427-33.
21. Kan Z, Wallace S. Sinusoidal embolization: impact of iodised oil on hepatic microcirculation. J Vasc Intervent Radiol 1994; 5:881-6.
22. Yumoto Y, Jinno K, Tokuyama K, Araki Y, Ishimitsu T, Maeda H, Konno T, Iwamoto S, Ohnishi K, Okuda K. Hepatocellular carcinoma detected by iodized oil. Radiology 1985; 154:19-24.
23. Nakao N, Uchida H, Kamino K, Nishimura Y, Ohishi H, Takayasu Y, Nakamura H, Kuroda C, Fujita M, Yashioka H, et al. Effectiveness of lipiodol in transcatheter arterial embolization of hepatocellular carcinoma. Cancer Chemother Pharmacol 1992; 31 (Suppl):S72-6.
24. Kasugai H, Kojima J, Tatsuta M, Okuda S, Sasaki Y, Imaoka S, Fujita M, Ishiguro S. Treatment of hepatocellular carcinoma by transcatheter arterial embolisation combined with intraarterial infusion of a mixture of cisplatin and ethiodised oil. Gastroenterology 1989; 97:965-71.
25. Jaeger HJ, Mehring UM, Castaneda F, Hasse F, Blumhardt G, Loehlein D, Mathias KD. Sequential transarterial chemoembolisation for unresectable advanced hepatocellular carcinoma. Cardiovasc Intervent Radiol 1996; 19:388-96.
26. Farinati F, Salvagnini M, de Maria N, Fornasieri A, Fagiuoli S, Chiaramonte M, Rossaro L, Naccarato R. Unresectable hepatocellular carcinoma: a prospective controlled trial with tamoxifen. J Hepatol 1990; 12:297-301.
27. CLIP Group (Cancer of the Liver Italian Programme). Tamoxifen in treatment of hepatocellular carcinoma: a randomised controlled trial. Lancet 1998;352:17-20.
28. Tanaka K, Inoue S, Numata K, Takamura Y, Takebayashi S, Ohaki Y, Misugi K. Color doppler sonography of hepatocellular carcinoma before and after treatment by transcatheter arterial embolisation. AJR 1992; 158:541-6.
29. Nakamura H, Tanaka T, Hori S, Yoshioka H, Kuroda C, Okamura J, Sakurai M. Transcatheter embolisation of hepatocellular carcinoma: assessment of efficacy in cases of resection following embolization. Radiology 1983; 147:401-5.
30. Hsu HC, Wei TC, Tsang YM, Wu MZ, Lin YH, Chuang SM. Histologic assessment of resected hepatocellular carcinoma after transcatheter hepatic arterial embolization. Cancer 1986; 57:1184-91.
31. Nakamura H, Hashimoto T, Oi H, Sawata S. Transcatheter oily chemoembolisation of hepatocellular carcinoma. Radiology 1989; 170:783-6.
32. Nagasue N, Yukaya H, Ogawa Y, Sasaki Y, Chang YC, Niimi K. Second hepatic resection for recurrent hepatocellular carcinoma. Br J Surg 1986; 73:434-8.
33. Nagao T, Inoue S, Yoshini F, Sodeyama M, Omori Y, Mizuta T, Kawano N, Morioka Y. Postoperative recurrence of hepatocellular carcinoma. Ann Surg 1990; 211:28-33.
34. Trinchet JC, Beaugrand M. Treatment of hepatocellular carcinoma in patients with cirrhosis. J Hepatol 1997; 27:756-65.
35. Dodds HM, Walpole ET, Rivory LP, Strong RW, Pond SM. Disposition of epirubicin after intraarterial administration in Lipiodol to patients with hepatocellular carcinoma. Ther Drug Monit 1996; 18:537-43.